Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®)
- 1 December 1973
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 6 (4) , 217-219
- https://doi.org/10.1007/bf00644734
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The effect of pindolol, a beta-receptor blocking agent, in heart rate and blood-pressure during submaximal and maximal exerciseEuropean Journal of Clinical Pharmacology, 1972
- New treatment for hypertensionEuropean Journal of Clinical Pharmacology, 1971
- Plasma propranolol levels in adults With observations in four childrenClinical Pharmacology & Therapeutics, 1970
- Treatment of Hypertension with PropranololBMJ, 1969
- A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animalsBritish Journal of Pharmacology, 1968
- Effect of Propranolol on Elevated Arterial Blood PressureCirculation, 1968
- The Paradox of Beta-Adrenergic Blockade in HypertensionCirculation, 1968
- [Comparative studies with beta-receptor blocking agents and quinidine].1967
- Propranolol in hypertensionThe American Journal of Cardiology, 1966
- Use of Propranolol (Inderal) in Treatment of HypertensionBMJ, 1964